insurance changes glp-1 Coverage Statistics 2026 | Employer, Medicare & Medicaid Data Major insurance changes are coming

Since GLP-1 medications can be expensive, its important to compare value for money

Consistent with these effects, GLP-1 RAs have been associated with substantial weight loss in clinical trials, leading to FDA approval of two of these agents liraglutide and semaglutide for chronic weight management in adults with obesity or with overweight and at least one weight-related comorbidity

It is a 37-residue C-terminally amidated peptide closed by a Cys2-Cys7 disulfide bridge, sequence KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH, with the Lys1 side chain acylated by a C20 fatty diacid through a gamma-glutamate linker

FDA reviewers cited weak evidence, poor characterization, differences between proposed and studied administration routes, and the availability of approved therapies for the conditions discussed